The current study aimed to develop long-acting protease-resistant GLP-1R agonists with the potential for administration in type 2 diabetes mellitus treatment by designing and computationally analyzing the fusion proteins of the native or protease-resistant mutant GLP-1 and an HSA-binding DARPin
Sulfur nanoparticles improved plant growth and reduced mercury toxicity via mitigating the oxidative stress in brassica napus l
After withdrawing therapy with oral semaglutide, in most cases, patients switched to an injectable GLP-1RA or to an SGLT2i, all drugs provided with demonstrated cardiovascular and renal protection [20]
Elution gradients were run starting from 98% B to 86% B from 0-7 min
Our products are manufactured in a sterile, controlled environment and are tested for purity and sterility
The surge in prescriptions for diabetes and obesity has created sustained pressure on manufacturing, distribution, and inventory management across multiple regions